Open-label olanzapine treatment in bipolar I disorder: clinical and work functional outcomes

Lizheng Shi; R. Juarez; Jodi Hackworth; E.T. Edgell; Josep María Haro; Eduard Vieta; Mauricio Tohen

doi:10.1185/030079906x104632

Related publications

Article2001

Olanzapine as Long-Term Adjunctive Therapy in Treatment-Resistant Bipolar Disorder

Eduard Vieta, María Reinares, Bàrbara Corbella, Antoni Benabarre, Inmaculada Gilaberte, Francesc Colom, Anabel Martínez‐Arán, Cristòbal Gastó, M. Tohen

Article2004

Effects on Weight and Outcome of Long-term Olanzapine-Topiramate Combination Treatment in Bipolar Disorder

Eduard Vieta, José Sánchez‐Moreno, José Manuel Goikolea, Francesc Colom, Anabel Martínez‐Arán, Antonio Benabarre, Bàrbara Corbella, Carla Torrent, Mercé Comes, María Reinares, Esteve Brugué

Article2004

Olanzapine in bipolar disorder

Eduard Vieta

Article2004

Comparison of Rapid-Cycling and Non–Rapid-Cycling Bipolar I Manic Patients During Treatment With Olanzapine

Eduard Vieta, Joseph R. Calabrese, John Hennen, Francesc Colom, Anabel Martínez‐Arán, José Sánchez‐Moreno, Lakshmi N. Yatham, Mauricio Tohen, Ross J. Baldessarini

Article2006

An open label follow-up study on amisulpride in the add-on treatment of bipolar I patients.

Mauro Carta, Fausta Zairo, Gisa Mellino, Maria Carolina Hardoy, Eduard Vieta

Open-label olanzapine treatment in bipolar I disorder: clinical and work functional outcomes

Abstract

Discussion(0)

Related publications

Olanzapine as Long-Term Adjunctive Therapy in Treatment-Resistant Bipolar Disorder

Effects on Weight and Outcome of Long-term Olanzapine-Topiramate Combination Treatment in Bipolar Disorder

Olanzapine in bipolar disorder

Comparison of Rapid-Cycling and Non–Rapid-Cycling Bipolar I Manic Patients During Treatment With Olanzapine

An open label follow-up study on amisulpride in the add-on treatment of bipolar I patients.